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Abstract 1 
 2 
Background/Objectives: Biomarkers for a mixed fruit and vegetable (FV) diet are needed to 3 
provide a better understanding of the association between FV intake and type 2 diabetes. We 4 
aimed to examine the prospective association between a composite score comprised of three 5 
biomarkers of FV intake in free-living populations and incident diabetes.  6 
 7 
Subjects/Methods: A total of 318 incident diabetes cases and 926 controls from the EPIC-8 
Norfolk study aged 40-79 years at baseline (1993-1997) completed 7-day food diaries (7DD) 9 
and had plasma vitamin C and carotenoid measures. A composite biomarker score (CB-score) 10 
comprising the sum of plasma vitamin C, beta-carotene and lutein was derived. Odds ratios 11 
(OR) and 95% confidence intervals for incident diabetes were estimated using multivariable 12 
logistic regression. 13 
 14 
Results: A strong inverse association was found between the CB-score and incident diabetes. 15 
The OR (95% CI) of diabetes comparing quartiles Q2, Q3 and Q4 of the CB-score with Q1 16 
(reference category) were 0.70 (0.49, 1.00), 0.34 (0.23, 0.52) and 0.19 (0.12, 0.32), 17 
respectively, and 0.49 (0.40, 0.58) per SD change in CB-score in a model adjusted for 18 
demographic and lifestyle factors. The association was marginally attenuated after 19 
additionally adjusting for BMI and waist circumference (0.60 (0.49, 0.74) per SD change in 20 
CB-score). 21 
 22 
Conclusions: A combination of biomarkers representing the intake of a mixed FV diet was 23 
strongly inversely associated with incident diabetes. These findings provide further support 24 
for measuring dietary biomarkers in studies of diet-disease associations and highlight the 25 
importance of consuming FV for the prevention of diabetes.  26 
 27 
Abbreviations: 28 
7DD, 7-day prospective food diary; CB-score, composite biomarker score; EPIC-Norfolk, 29 
European Prospective Investigation of Cancer – Norfolk; FV, fruit and vegetables; IARC, 30 
International Agency for Research on Cancer. 31 
32 
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Introduction 33 
 34 
Fruit and vegetable (FV) intake has been advocated for the prevention of type 2 diabetes (1), 35 
but the epidemiological findings are inconsistent (2-7). This is likely due, in part, to the fact 36 
that FV intake has traditionally been assessed using self-report methods (8), which are prone 37 
to misclassification and reporting biases (9, 10). Thus, clarification of the association between 38 
FV intake and diabetes requires objective measures of intake/exposure.  39 
 40 
FVs are the primary source of vitamin C and carotenoids in the diet. As these phytochemicals 41 
cannot be synthesised by humans, plasma levels have been explored as biomarkers of FV 42 
intake (11, 12). However, whilst vitamin C and carotenoids (e.g. alpha-carotene, beta-carotene 43 
and lycopene) can be considered good biomarkers for the intake of specific fruits or 44 
vegetables, or a particular group of FV (11), they are not, by themselves, good biomarkers of 45 
a mixed FV diet (13). Thus, a combination of different phytochemicals may better reflect a 46 
mixed FV diet than a single phytochemical in isolation (14-16). Intervention studies in 47 
humans have consistently demonstrated that plasma vitamin C is a good marker of fruit intake 48 
(13), and that vitamin C, alpha-carotene, beta-carotene and lutein are particularly responsive 49 
to changes in total FV intake among free-living populations (13). Furthermore, vitamin C, 50 
beta-carotene and lutein are individually associated with the intake of different types of FV, 51 
and are not strongly correlated with one another (11). Thus, a summary score of these 52 
compounds likely provides a more suitable measure than self-report or single biomarkers in 53 
isolation when examining the association between a mixed FV diet and risk of diabetes. As 54 
far as we are aware, no prospective studies have yet examined the association between a 55 
combined panel of different biomarkers, previously demonstrated to be sensitive to FV intake, 56 
and the risk of incident diabetes.  57 
 58 
The objective of this study was to examine the association between a combined biomarker 59 
score comprised of vitamin C, beta-carotene and lutein and risk of incident diabetes. 60 
 61 
Materials/Subjects and Methods 62 
Study population 63 
The Norfolk component of the European Prospective Investigation of Cancer (EPIC-Norfolk) 64 
study recruited 25,639 men and women aged 40-79 years at baseline in 1993-97. The cohort 65 
was representative of the general population of England and Wales for age and sex 66 
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distribution, anthropometric measures, blood pressure and serum lipids but differed in that 67 
99.7% of the cohort was white Caucasian (17). The recruitment procedures, collection of 68 
questionnaire data, and anthropometric and dietary measures have been described in detail 69 
elsewhere (17, 18). All volunteers gave written informed consent and the study was approved 70 
by the Norwich district ethics committee. 71 
 72 
Participant selection and case ascertainment 73 
Plasma carotenoids were available for 7 495 participants selected from case-control studies 74 
nested within the EPIC-Norfolk study. A sample of 1 160 of these controls was selected with 75 
a similar age and sex distribution to the full EPIC-Norfolk cohort with baseline health checks 76 
(n=25 639). Within this sample, 1 131 participants were free from diabetes and had plasma 77 
vitamin C and carotenoids available. Among these, 926 participants had data for potential 78 
confounders and were included in this analysis (Figure 1 shows the flow diagram of 79 
participant selection). These participants are representative of the entire EPIC-Norfolk cohort 80 
in terms of age, sex, BMI, education level, physical activity level, smoking status, total energy 81 
intake, and plasma vitamin C levels (data not shown). 82 
 83 
We ascertained 892 incident diabetes cases up until the 31st of July 2006 by self-report of 84 
doctor-diagnosed diabetes or diabetes medication use that was self-reported or brought to the 85 
second health check, as reported elsewhere (19). In addition, external sources of information 86 
through record linkage included general practice and hospital diabetes registers, hospital 87 
admissions data and Office of National Statistics mortality data with coding for diabetes. 88 
Participants who gave a self-report of history of diabetes that could not be confirmed against 89 
any other sources of ascertainment were not considered as a confirmed case of diabetes. After 90 
excluding type 2 diabetes cases without available plasma vitamin C and carotenoid measures 91 
(n=440), and those with missing data for potential confounders (n=134), 318 diabetes cases 92 
were included for this analysis. Cases are representative of all EPIC-Norfolk diabetes cases in 93 
terms of age, sex, BMI, education level, physical activity level, smoking status, total energy 94 
intake, and plasma vitamin C levels (data not shown). 95 
 96 
Biomarker assessment and calculation of the composite biomarker z-score 97 
Blood samples were taken by venepuncture at the baseline medical examination. Following 98 
overnight storage in a dark box at 4-7˚C, the sample aliquots were spun in a centrifuge at 99 
2100 g for 15 min at 4˚C. Plasma vitamin C was measured from blood collected into citrate 100 
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tubes and the plasma was stabilized in a standardized volume of metaphosphoric acid and 101 
stored at -70˚C. Plasma vitamin C concentration was estimated with a fluorometric assay 102 
within one week of sampling. The coefficient of variation was 5.6% at the lower end of the 103 
range (mean, 33.2 µmol/L) and 4.6% at the upper end of the range (mean, 102.3 µmol/L).  104 
 105 
Plasma samples of beta-carotene and lutein were analysed at the International Agency for 106 
Research on Cancer (IARC) using a reverse-phase high-performance liquid chromatography 107 
method (HPLC) (20) on an HPLC-1100 system (Hewlett Packard, Wilmington, IL, USA) 108 
with a C18-Adsorbosphere column (Alltech, Deerfield, IL, USA). As previously described 109 
(21), plasma samples (200 µl) were thawed and deproteinated with alcohol, extracted with 110 
hexane, dried under vacuum and then reconstituted with 300 µl of a mixture of methanol 111 
(88%)/ethanol (10%)/hexane (2%). Internal standards were run with each sample, and in each 112 
batch an external calibration was performed using the standard solution at eight different 113 
concentrations. The coefficient of variation was 5.5% for beta-carotene and 4.3% for lutein. 114 
 115 
We derived a combined biomarker score (CB-score) for total FV intake based on findings 116 
from a recent systematic review of biomarkers of FV intake in human intervention studies 117 
(13). The biomarkers that were most consistently and positively associated with increases in 118 
FV intake were selected, and included: plasma vitamin C (increased in 21 out of 29 studies 119 
(72.4%)), beta-carotene (increased in 36 out of 46 studies (78.3%)), alpha-carotene (increased 120 
in 31 out of 42 studies (73.8%)) and lutein (increased in 19 out of 27 studies (70.4%)). 121 
Because beta-carotene and alpha-carotene are present in similar FV (e.g. carrots), and highly 122 
correlated (11), we excluded alpha-carotene in favour of beta-carotene because beta-carotene 123 
is more strongly correlated with total FV intake (11, 13).  124 
 125 
A combined CB-score was calculated by summing standardised values for plasma levels of 126 
vitamin C, beta-carotene and lutein. Variables were standardised by subtracting the sample 127 
mean from the individual mean and dividing by the SD. Finally, we divided the score by three 128 
to account for the number of individual biomarkers included in the CB-score.  129 
 130 
Baseline characteristics and dietary data 131 
At recruitment participants completed a detailed health and lifestyle questionnaire. 132 
Participants self-reported their education level (low, O level, A level, degree), occupational 133 
social class (manual, non-manual), smoking status (current, former, never), and baseline 134 
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history (yes, no) of myocardial infarction, stroke and cancer. A four point physical activity 135 
index was derived incorporating occupational and leisure-time components of physical 136 
activity, as previously described in detail (22). Trained nurses measured height, weight and 137 
waist circumference following standardized protocols. BMI was calculated as weight divided 138 
by the square of height (kg/m
2
) (17). 139 
 140 
Diet was assessed at baseline using a 7-day prospective food diary (7DD) (18). Diary data 141 
were coded and analysed with a specially developed programme for extraction of food and 142 
average daily nutrient intakes (23). The 7DD has been validated with weighed food records, 143 
24-hour urine collections and blood biomarkers (24). 144 
 145 
Statistics 146 
Baseline characteristics were summarised by quartiles of the CB-score among controls, using 147 
means with SDs, medians with interquartile ranges (IQR) or frequencies. Multivariable 148 
logistic regression was used to estimate the association between the CB-score and the odds of 149 
diabetes, both per SD increase and by categorising the CB-score into quartiles (with the 150 
lowest quartile as the reference category), based on the distribution of the CB-score among 151 
controls. We adjusted for age, sex (Model 1), education level, occupational social class, 152 
smoking status, physical activity level, family history of diabetes, total energy intake and 153 
vitamin supplement use (Model 2). HDL- and LDL-cholesterol were also included in Model 2 154 
as their concentration can influence carotenoid levels and confound the interpretation of status 155 
with disease risk (25). BMI and waist circumference were examined as potential mediators of 156 
the association (Model 3) because an association between FV intake and diabetes may be 157 
mediated by body weight (26). Multiplicative interaction terms were added to model 2 to 158 
examine effect modification by sex, age (<60 years, ≥60 years), BMI (normal weight: <25 159 
kg/m
2, overweight/obese: ≥25 kg/m2), and smoking status (never smoker, ever smoker). A 160 
similar analytical approach was used to examine the association of plasma vitamin C, beta-161 
carotene and lutein individually with diabetes. The relative increase in FV intake per SD 162 
increase in the CB-score was estimated using linear regression including the CB-score with 163 
FV intake. 164 
 165 
In sensitivity analyses, the association between the CB-score and odds of diabetes was 166 
investigated by including other potentially confounding dietary variables in model 2, 167 
including percentage of energy from carbohydrate, protein, fat, and alcohol intake 168 
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(continuous). Analyses were repeated after excluding participants who developed diabetes 169 
within the first two years of follow-up (n=12). Statistical analyses were performed using 170 
Stata/SE 13.1 (Stata-Corp, College Station, Texas, USA).  171 
 172 
Results 173 
The mean (SD) duration of follow-up of all participants (n=1 244) was 10.2 (1.2) years. The 174 
differences between the means of the highest and lowest quartiles of the CB-score were 36.1 175 
μmol/l for vitamin C, 23.9 μg/dL for beta-carotene and 12.4 μg/dL for lutein (Table 1). Mean 176 
combined self-reported FV intake was 175.9 g/d higher among those in the highest compared 177 
with those in the lowest quartile of the CB-score. Each SD increase in the CB-score was equal 178 
to a 70.6 g/d (95% CI: 62.1-79.2 g) increase in FV intake. Comparing baseline characteristics 179 
by quartiles of the CB-score (Table 2), higher levels of the CB-score were associated with 180 
more favourable profiles for almost all covariates, including education level, occupational 181 
social class, smoking status, physical activity level, vitamin supplement use and fat intake. 182 
The CB-score was positively correlated with combined FV intake (Pearson’s r=0.42,) to a 183 
higher degree than were vitamin C (r=0.37), beta-carotene (r=0.30) or lutein (r=0.24) 184 
separately.  185 
 186 
The CB-score was strongly inversely associated with the odds of diabetes comparing the 187 
highest with lowest quartile (Model 1, OR: 0.13; 95% CI: 0.08, 0.21) (Table 3). After 188 
adjustment for demographic and lifestyle factors, the inverse association remained largely 189 
unchanged (Model 2, OR: 0.19; 95% CI: 0.12, 0.32). Each SD increase in CB-score was 190 
associated with a 51% (OR: 0.49, 95% CI: 0.40-0.58) reduced odds of diabetes (Model 2). 191 
Results were largely unchanged after excluding participants who developed diabetes within 192 
the first two years of follow-up (OR per SD increase in model 2: 0.49, 95% CI: 0.40-0.59). 193 
Adding carbohydrate, protein, fat, and alcohol intake to model 2 made no difference to the 194 
association of the CB-score with the odds of diabetes. There was a modest attenuation in the 195 
association upon the inclusion of BMI and waist circumference in the model (Table 3). For 196 
instance, for each SD increase in CB-score (Model 3) the OR was 0.60 (95% CI: 0.49-0.74) as 197 
opposed to 0.49 (95% CI: 0.40-0.58) when BMI and waist circumference were not included 198 
(Model 2). There were no significant interactions between the CB-score and sex (p=0.23), age 199 
(p=0.64), BMI (p=0.48) or smoking status (p=0.38). Plasma vitamin C, beta-carotene and 200 
lutein were individually inversely associated with diabetes, with the strongest association 201 
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being observed for beta-carotene (OR per SD increase in model 2: 0.51, 95% CI: 0.40-0.63) 202 
(Table 3). 203 
 204 
Discussion 205 
In this prospective study of men and women from the EPIC-Norfolk cohort, higher levels of a 206 
combined biomarker score including plasma vitamin C, beta-carotene and lutein were 207 
independently and strongly inversely associated with incident diabetes. For each SD increase 208 
in the CB-score, which is equivalent to approximately 70 g per day (or nearly one portion – 209 
assuming a standard portion size of 80 grams) increase in FV intake, the odds of diabetes was 210 
reduced by 40% (OR: 0.60, 95% CI: 0.49-0.74). These findings are consistent with the notion 211 
that FVs, which are the main dietary sources of these compounds, have a significant 212 
beneficial effect on the risk of developing diabetes.  213 
 214 
There are several important strengths of our study including the prospective study design, use 215 
of a composite score comprised of biomarkers shown to be responsive to increases in a mixed 216 
FV diet in free-living populations, thorough assessment of incident cases of diabetes with 217 
self-report information supplemented by external sources, and comprehensive information on 218 
demographic and other lifestyle characteristics. Furthermore, as we were able to exclude 219 
incident diabetes cases diagnosed within the first two years of follow-up we have been able to 220 
minimise the possibility that our findings are explained by reverse causality. Potential 221 
limitations of our study also merit discussion. We used baseline biomarker levels to 222 
characterise individuals and did not take into account the possible misclassification of 223 
individuals with respect to their habitual levels. Nevertheless, this measurement error is most 224 
likely random, the effect of which would be to attenuate the observed ORs towards the null, 225 
suggesting that the true association between the CB-score and diabetes may be stronger than 226 
reported in the current study. Because of the observational nature of the study, we cannot 227 
exclude the possibility of residual confounding or confounding by unmeasured factors. 228 
Finally, as plasma biomarker levels can be affected by a number of other factors (e.g. age, 229 
BMI, smoking status, and genetic variation (27)), FV intake is likely to be only one of several 230 
determinants of our CB-score. However, we have demonstrated that irrespective of whether 231 
our CB-score is determined by dietary intake of FV or other factors, it is still strongly 232 
associated with incident diabetes. 233 
 234 
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Although FV intake has been associated with a lower risk of diabetes in some studies, the 235 
associations are inconsistent (8). This is likely due to measurement error in ascertaining 236 
dietary intake, the consequence of which is underestimation of relative risks and reduced 237 
statistical power to detect diet-disease associations (28). Comparable with our current 238 
findings, in a previous EPIC-Norfolk analysis (4), which included follow-up of over 22 000 239 
men and women for 12 years, there was a borderline significant OR of diabetes comparing the 240 
highest with lowest quintile of FV intake (OR: 0.78, 95% CI: 0.60-1.00), as assessed by FFQ. 241 
Yet, when the same association was examined using plasma vitamin C as a biomarker of FV 242 
intake, the highest compared with lowest quintile of plasma vitamin C was independently 243 
associated with a much stronger 62% (95% CI: 48-72%) reduction in diabetes risk.  244 
 245 
We selected a combination of vitamin C, beta-carotene and lutein to form a CB-score for a 246 
mixed FV diet based on evidence from human intervention studies (13) as these compounds 247 
are individually associated to a greater or lesser degree with different types of FV (e.g. citrus 248 
fruits are rich in vitamin C; apricots, spinach and carrots are rich sources of beta-carotene, and 249 
broccoli, kale, and green peas are rich sources of lutein). Our finding of the strongest 250 
correlation between the CB-score and total FV assessed by the 7-day diary, versus more 251 
modest correlations with individual biomarkers is in line with this evidence. Our observation 252 
that the association of the CB-score with diabetes was comparable to the individual 253 
constituent biomarkers is likely explained by the fact that the participants in our cohort 254 
consume a wide range of FVs, and as such a single biomarker for the intake of citrus fruits for 255 
example (i.e. plasma vitamin C) correlates highly with the intake of other FVs. Consequently, 256 
the magnitude of the association with diabetes is equivalent when the ranking of participants 257 
remains similar. To clarify the utility of a CB-score in different populations with varying 258 
patterns of intake of FV, future research comparing this combined biomarker score with 259 
individual biomarkers in populations who consume predominantly fruits or vegetables, or 260 
selected groups of fruits or vegetables e.g. root vegetables, are needed. 261 
 262 
That we observed a small amount of effect attenuation by BMI and waist circumference 263 
suggests that one mechanism by which FV intake may be inversely associated with diabetes 264 
risk is via an association with body weight, the most potent modifiable risk factor for diabetes 265 
(29, 30). In a study of over 89 000 men and women from the EPIC-Europe study, Buijsse et al 266 
(26) showed a 14 gram per year lower mean weight change for each 100 g/d increase in FV 267 
intake (95% CI: -19, -9 g/y). Similarly, in the Nurses’ Health Study, participants with the 268 
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largest increase in FV intake had a 24% lower risk of becoming obese compared with those 269 
who had a decrease in FV intake, independent of other potential confounding factors (31). In 270 
the current study, bearing in mind that BMI and waist circumference only had a minor 271 
attenuating effect on the observed association (OR of 0.60 [95% CI: 0.49-0.74] including 272 
BMI and waist circumference as opposed to an OR of 0.49 [95% CI: 0.40-0.58] excluding 273 
BMI and waist circumference), it is clear that further research is required to elucidate other 274 
pathophysiological pathways linking FV intake with diabetes.  275 
 276 
It has been suggested that vitamin C and carotenoids may exert their beneficial effects 277 
through the oxidative stress pathway (32, 33). However, several randomised controlled trials 278 
of antioxidant supplementation, including beta-carotene and/or vitamin C, have reported no 279 
effect of supplementation on either fasting plasma glucose levels or diabetes risk (34-37). In 280 
contrast, observational studies demonstrate a reduced risk of diabetes among participants with 281 
high vitamin C and carotenoid intakes (4, 38) or high blood concentrations (4, 39). The 282 
discrepancy between trials and observational studies (4, 34-39) may be explained by the fact 283 
that FV are also a primary source of many other bioactive phytochemicals as well as having a 284 
high fibre content and low energy density, properties which are almost impossible to mimic in 285 
pill form (as used in vitamin supplements). Moreover, a measure of one biomarker (e.g. 286 
vitamin C) is likely to be a good marker for a host of other poorly defined or unknown 287 
phytochemicals. Thus, if the measured biomarker has no beneficial effect on diabetes risk, but 288 
the unmeasured or unknown phytochemical is highly correlated with the biomarker and is 289 
protective, then it may erroneously be concluded that the measured biomarker is the 290 
protective factor (40). As such, our findings do not establish that the association with diabetes 291 
is specific to vitamin C, beta-carotene or lutein as distinct from other phytochemicals and 292 
mechanisms by which FV intake may confer a protective effect.  293 
 294 
Our findings of a strong inverse association between a combined biomarker score comprised 295 
of vitamin C, beta-carotene and lutein and diabetes suggests that this score is likely to be a 296 
good biomarker of compounds or mechanisms which affect diabetes, most likely the dietary 297 
intake of FV. These findings provide strong support for measuring dietary biomarkers in 298 
future diet-disease association studies, but also highlight the need for future studies to 299 
examine the utility of a combined biomarker score with diabetes risk in populations with 300 
heterogeneous intake of fruits and vegetables. 301 
302 
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Figure 1. Flow diagram of participant selection: the EPIC-Norfolk Study. 
